Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 14
- Locations
- 1
- Primary Endpoint
- Study Completion
Study Overview
Brief Summary
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Detailed Description
A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Device Feasibility
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Stage I-III Non-small cell lung cancer survivors
- •Must be at >6-weeks and < 3 years post-surgical resection
- •Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria
- •Individuals clinically unstable.
- •Mania, Bipolar disease or seizure disorder
- •Macular degeneration or glaucoma.
- •Currently receiving chemotherapy or radiation.
Arms & Interventions
Experimental
Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.
Intervention: Morning bright light therapy (Device)
Attention Control
Exposure to dim light delivered with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.
Intervention: Dim light (Device)
Outcomes
Primary Outcomes
Study Completion
Time Frame: Baseline
The percentage of participants recruited that completed the study
Secondary Outcomes
No secondary outcomes reported
Investigators
Carleara Weiss
Principal Investigator
State University of New York at Buffalo